Skip to content

Clinical trials

Phase 2 Graves Ophthalmopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Phase: Phase 2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20141
20171
20193
20202
20233
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Recruiting3
Unknown status3
Not yet recruiting1
Withdrawn1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
Amgen2
Immunovant Sciences GmbH2
University of Pisa2
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
GlaxoSmithKline1
Haukeland University Hospital1
Innovent Biologics (Suzhou) Co. Ltd.1
Ipsen1
Johns Hopkins University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy19
Exophthalmos3
Eye Diseases3
Graves Disease3
Hyperthyroidism3
Endocrine System Diseases2
Thyroid Diseases2
Autoimmune Diseases1
Eye Diseases, Hereditary1
Hypercholesterolemia1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.